PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 65 filers reported holding PROTAGONIST THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $494,500 | +110.8% | 21,500 | 0.0% | 0.00% | – |
| Q4 2022 | $234,565 | -81.9% | 21,500 | -86.9% | 0.00% | -100.0% |
| Q2 2022 | $1,298,000 | -58.7% | 164,075 | +23.6% | 0.00% | -50.0% |
| Q1 2022 | $3,144,000 | -31.8% | 132,734 | -1.5% | 0.00% | -33.3% |
| Q4 2021 | $4,611,000 | +429.4% | 134,793 | +174.1% | 0.00% | +200.0% |
| Q3 2021 | $871,000 | -73.9% | 49,171 | -33.8% | 0.00% | -66.7% |
| Q2 2021 | $3,333,000 | +73.3% | 74,260 | 0.0% | 0.00% | +50.0% |
| Q1 2021 | $1,923,000 | +28.4% | 74,260 | 0.0% | 0.00% | +100.0% |
| Q4 2020 | $1,498,000 | +3.2% | 74,260 | 0.0% | 0.00% | -50.0% |
| Q3 2020 | $1,452,000 | +8.5% | 74,260 | -2.0% | 0.00% | 0.0% |
| Q2 2020 | $1,338,000 | +85.8% | 75,790 | -25.8% | 0.00% | +100.0% |
| Q1 2020 | $720,000 | +42.0% | 102,098 | +41.8% | 0.00% | – |
| Q4 2019 | $507,000 | -63.4% | 72,001 | -36.4% | 0.00% | -100.0% |
| Q3 2019 | $1,385,000 | -7.9% | 113,276 | -8.7% | 0.00% | 0.0% |
| Q2 2019 | $1,503,000 | +55.4% | 124,090 | +61.3% | 0.00% | 0.0% |
| Q1 2019 | $967,000 | – | 76,915 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $20,647,000 | 6.08% |
| Bain Capital Life Sciences Investors, LLC | 2,260,572 | $19,057,000 | 2.28% |
| Kynam Capital Management, LP | 519,212 | $4,377,000 | 0.92% |
| RTW INVESTMENTS, LP | 4,176,837 | $35,211,000 | 0.81% |
| Tri Locum Partners LP | 199,500 | $1,682,000 | 0.46% |
| Birchview Capital, LP | 38,000 | $320,000 | 0.22% |
| Gratus Capital, LLC | 206,113 | $1,738,000 | 0.18% |
| FARALLON CAPITAL MANAGEMENT LLC | 3,651,887 | $30,785,000 | 0.17% |
| PDT Partners, LLC | 126,038 | $1,063,000 | 0.16% |
| FOX RUN MANAGEMENT, L.L.C. | 40,683 | $343,000 | 0.13% |